Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 228

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 228
---
162, respectively.

5. INTANGIBLE ASSETS

As of December 31, 2024 and 2023, Intangible Assets, net consist of:

|                            |     |   | December 31, 
         2024 |   |     |   | December 31, 
         2023 |   |
|:---------------------------|:----|:--|-------------:|:--|:----|:--|-------------:|:--|
| Patents                    |     | $ |      127,603 |   |     | $ |      185,595 |   |
| Website Development Costs  |     |   |      104,622 |   |     |   |       79,248 |   |
| Intangible Assets, at cost |     |   |      232,225 |   |     |   |      264,843 |   |
| Accumulated Amortization   |     |   |      (75,141 | ) |     |   |      (37,585 | ) |
| Intangible Assets, net     |     | $ |      157,084 |   |     | $ |      227,258 |   |

During the years ended December 31, 2024 and 2023, the Company capitalized website development-related costs of $ 25,374and $ 52,178, respectively, in connection with the upgrade and enhancement of functionality of the corporate website at www.60degreespharma.com. Amortization expense for the years ended December 31, 2024, and 2023 was in the amount of $ 38,502and $ 29,157, respectively.

The following table summarizes the estimated future amortization expense for our patents and website development costs as of December 31, 2024:

| Period     |     | Patents |        |     | Website Development Costs |        |
|:-----------|:----|:--------|-------:|:----|:--------------------------|-------:|
| 2025       |     | $       |  6,810 |     | $                         | 31,761 |
| 2026       |     |         |  6,810 |     |                           | 12,432 |
| 2027       |     |         |  6,810 |     |                           |  3,094 |
| 2028       |     |         |  6